🇺🇸 FDA
Patent

US 12037410

Methods and compositions for targeting Treg cells

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 12037410 (Methods and compositions for targeting Treg cells) held by PRECISION BIOLOGICS, INC. expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRECISION BIOLOGICS, INC.
Grant date
Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K39/395, A61K45/06